6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
2 followers
Gilead Sciences
147 followers
Regeneron
111 followers
Illumina
76 followers
Agilent Technologies
76 followers
Verily Life Sciences
41 followers
Alexion Pharmaceuticals
40 followers
Explore companies